tiprankstipranks
Halozyme Therapeutics (HALO)
NASDAQ:HALO
US Market
HALO
Halozyme
RESEARCH TOOLSreports

Halozyme (HALO) Ratios

1,173 Followers

Halozyme Ratios

HALO's free cash flow for Q4 2025 was $0.77. For the 2025 fiscal year, HALO's free cash flow was decreased by $ and operating cash flow was $0.56. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.66 4.66 7.80 6.64 5.65
Quick Ratio
 3.66 3.66 6.78 5.50 4.88
Cash Ratio
 0.76 0.76 0.83 1.05 1.79
Solvency Ratio
 0.18 0.16 0.31 0.22 0.15
Operating Cash Flow Ratio
 3.68 3.68 3.44 3.45 1.84
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 18.01
Net Current Asset Value
$ -1.65B$ -1.65B$ -614.32M$ -903.04M$ -932.70M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.73 0.86 0.82
Debt-to-Equity Ratio
 0.00 0.00 4.14 17.89 8.87
Debt-to-Capital Ratio
 0.00 0.00 0.81 0.95 0.90
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.81 0.95 0.90
Financial Leverage Ratio
 51.73 51.73 5.67 20.68 10.85
Debt Service Coverage Ratio
 44.93 41.62 30.04 20.53 8.87
Interest Coverage Ratio
 45.03 45.03 30.48 17.99 15.79
Debt to Market Cap
 0.00 0.00 0.25 0.31 0.19
Interest Debt Per Share
 0.15 0.15 12.02 11.51 11.13
Net Debt to EBITDA
 -0.14 -0.15 2.12 3.06 4.03
Profitability Margins
Gross Profit Margin
81.95%78.13%84.30%76.80%78.90%
EBIT Margin
59.81%58.45%56.65%44.27%40.28%
EBITDA Margin
69.05%64.75%64.66%54.50%47.80%
Operating Profit Margin
58.45%58.45%54.32%40.71%40.53%
Pretax Profit Margin
33.43%33.43%54.87%42.01%37.71%
Net Profit Margin
22.69%22.69%43.74%33.96%30.62%
Continuous Operations Profit Margin
22.69%22.69%43.74%33.96%30.62%
Net Income Per EBT
67.87%67.87%79.71%80.84%81.20%
EBT Per EBIT
57.19%57.19%101.03%103.19%93.04%
Return on Assets (ROA)
12.55%12.55%21.52%16.25%10.98%
Return on Equity (ROE)
92.67%649.18%122.06%336.00%119.04%
Return on Capital Employed (ROCE)
34.76%34.76%28.66%20.83%15.64%
Return on Invested Capital (ROIC)
23.59%23.59%22.84%16.84%12.60%
Return on Tangible Assets
32.89%32.89%35.67%33.38%22.82%
Earnings Yield
4.01%3.93%7.32%5.78%2.60%
Efficiency Ratios
Receivables Turnover
 3.16 3.16 3.29 3.54 2.86
Payables Turnover
 12.07 14.61 15.55 16.28 7.87
Inventory Turnover
 1.43 1.73 1.12 1.51 1.39
Fixed Asset Turnover
 17.00 17.00 13.53 11.06 8.74
Asset Turnover
 0.55 0.55 0.49 0.48 0.36
Working Capital Turnover Ratio
 2.45 1.75 1.29 1.34 0.93
Cash Conversion Cycle
 340.53 301.24 412.22 322.79 343.75
Days of Sales Outstanding
 115.33 115.33 110.89 103.09 127.77
Days of Inventory Outstanding
 255.46 210.89 324.80 242.12 262.34
Days of Payables Outstanding
 30.25 24.97 23.47 22.42 46.36
Operating Cycle
 370.78 326.22 435.69 345.21 390.11
Cash Flow Ratios
Operating Cash Flow Per Share
 5.54 5.44 3.78 2.95 1.75
Free Cash Flow Per Share
 5.48 5.38 3.69 2.83 1.72
CapEx Per Share
 0.06 0.06 0.08 0.12 0.04
Free Cash Flow to Operating Cash Flow
 0.99 0.99 0.98 0.96 0.98
Dividend Paid and CapEx Coverage Ratio
 93.48 93.48 44.79 25.41 49.92
Capital Expenditure Coverage Ratio
 93.48 93.48 44.79 25.41 49.92
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.32 0.26 0.16
Operating Cash Flow to Sales Ratio
 0.47 0.47 0.47 0.47 0.36
Free Cash Flow Yield
8.14%7.99%7.72%7.66%3.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 23.62 25.45 13.65 17.32 38.52
Price-to-Sales (P/S) Ratio
 5.37 5.77 5.97 5.88 11.80
Price-to-Book (P/B) Ratio
 153.32 165.22 16.67 58.18 45.86
Price-to-Free Cash Flow (P/FCF) Ratio
 11.64 12.51 12.95 13.06 33.09
Price-to-Operating Cash Flow Ratio
 11.49 12.38 12.66 12.55 32.43
Price-to-Earnings Growth (PEG) Ratio
 -0.51 -1.04 0.21 0.39 -0.80
Price-to-Fair Value
 153.32 165.22 16.67 58.18 45.86
Enterprise Value Multiple
 7.64 8.77 11.35 13.84 28.71
Enterprise Value
 7.78B 7.93B 7.45B 6.26B 9.06B
EV to EBITDA
 8.07 8.77 11.35 13.84 28.71
EV to Sales
 5.57 5.68 7.34 7.55 13.72
EV to Free Cash Flow
 12.07 12.30 15.91 16.76 38.50
EV to Operating Cash Flow
 11.94 12.17 15.56 16.10 37.73
Tangible Book Value Per Share
 -12.86 -12.63 -3.59 -6.11 -5.74
Shareholders’ Equity Per Share
 0.41 0.41 2.87 0.64 1.24
Tax and Other Ratios
Effective Tax Rate
 0.32 0.32 0.20 0.19 0.19
Revenue Per Share
 11.87 11.65 8.01 6.29 4.82
Net Income Per Share
 2.69 2.64 3.50 2.13 1.48
Tax Burden
 0.68 0.68 0.80 0.81 0.81
Interest Burden
 0.56 0.57 0.97 0.95 0.94
Research & Development to Revenue
 0.06 0.06 0.08 0.09 0.10
SG&A to Revenue
 0.14 0.14 0.15 0.00 0.00
Stock-Based Compensation to Revenue
 0.03 0.04 0.04 0.04 0.04
Income Quality
 2.06 2.06 1.08 1.38 1.19
Currency in USD